Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-08-061011
Filing Date
2008-11-04
Accepted
2008-11-04 16:43:26
Documents
1
Period of Report
2007-12-30

Document Format Files

Seq Description Document Type Size
1 v130465_ex.html 4  
1 v130465_ex.xml 4 6548
  Complete submission text file 0001144204-08-061011.txt   8420
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Issuer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVE NEW YORK NY 10022
Business Address C/O PARAMONT CAPITAL INC 787 SEVENTH AVENE 44TH FL NEW YORK NY 10019 2125315965
WEISS MICHAEL S (Reporting) CIK: 0001038977 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51310 | Film No.: 081161344